LAUSR

Larson, R.A. & Bloomfield, C.D. (2005) Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B Study. Journal of Clinical Oncology, 23, 5705–5717. Qin, Y.Z., Xu, L.P., Chen, H., Jiang, Q., Wang, Y., Jiang, H., Zhang, X.H., Han, W., Chen, Y.H., Wang, F.R., Wang, J.Z., Zhu, H.H., Liu, Y.R., Jiang, B., Liu, K.Y. & Huang, X.J. (2015) Allogeneic stem cell transplant may improve the outcome of adult patients with inv(16) acute myeloid leukemia in first complete remission with poor molecular responses to chemotherapy. Leukemia & Lymphoma, 56, 3116–3123. Schlenk, R.F., Benner, A., Krauter, J., B€ uchner, T., Sauerland, C., Ehninger, G., Schaich, M., Mohr, B., Niederwieser, D., Krahl, R., Pasold, R., D€ ohner, K., Ganser, A., D€ ohner, H. & Heil, G. (2004) Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup. Journal of Clinical Oncology, 22, 3741– 3750. Wang, Y., Liu, Q.F., Xu, L.P., Liu, K.Y., Zhang, X.H., Ma, X., Fan, Z.P., Wu, D.P. & Huang, X.J. (2015) Haploidentical vs. identical-sibling transplant for AML in remission: a multicenter, prospective study. Blood, 125, 3956–3962. Yoon, J.H., Kim, H.J., Kim, J.W., Jeon, Y.W., Shin, S.H., Lee, S.E., Cho, B.S., Eom, K.S., Kim, Y.J., Lee, S., Min, C.K., Cho, S.G., Lee, J.W., Min, W.S. & Park, C.W. (2014) Identification of molecular and cytogenetic risk factors for unfavorable core-binding factor-positive adult AML with post-remission treatment outcome analysis including transplantation. Bone Marrow Transplantation, 49, 1466–1474.